Doyle Mittie 4
4 · Avalo Therapeutics, Inc. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
Doyle Mittie
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-12-10$4.10/sh−1,013$4,153→ 3,622 total
Footnotes (1)
- [F1]Includes 3,622 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.